Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Critical window hypothesis of hormone therapy and cognition: a scientific update on clinical studies.

Maki PM.

Menopause. 2013 Jun;20(6):695-709. doi: 10.1097/GME.0b013e3182960cf8. Review.

PMID:
23715379
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

EMAS position statement: managing the menopause in women with epilepsy.

Erel CT, Brincat M, Gambacciani M, Lambrinoudaki I, Moen MH, Schenck-Gustafsson K, Tremollieres F, Vujovic S, Rozenberg S, Rees M.

Maturitas. 2010 Jul;66(3):327-8. doi: 10.1016/j.maturitas.2010.03.026. Epub 2010 Apr 24. Review. Erratum in: Maturitas. 2011 Jun;69(2):e3.

PMID:
20418030
[PubMed - indexed for MEDLINE]
3.

Hormone therapy and cognitive function.

Maki PM, Sundermann E.

Hum Reprod Update. 2009 Nov-Dec;15(6):667-81. doi: 10.1093/humupd/dmp022. Epub 2009 May 25. Review.

PMID:
19468050
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.

American College of Obstetricians and Gynecologists Committee on Gynecologic Practice.

Obstet Gynecol. 2008 Nov;112(5):1189-92. doi: 10.1097/AOG.0b013e31818e8782.

PMID:
18978127
[PubMed - indexed for MEDLINE]
5.

Hormone replacement therapy and stroke.

Billeci AM, Paciaroni M, Caso V, Agnelli G.

Curr Vasc Pharmacol. 2008 Apr;6(2):112-23. Review.

PMID:
18393913
[PubMed - indexed for MEDLINE]
6.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
[PubMed - indexed for MEDLINE]
7.

Recent epidemiological evidence relevant to the clinical management of the menopause.

Shapiro S.

Climacteric. 2007 Oct;10 Suppl 2:2-15. Review.

PMID:
17882666
[PubMed - indexed for MEDLINE]
8.

Changes in postmenopausal hormone therapy use since 1988.

Kim JK, Alley D, Hu P, Karlamangla A, Seeman T, Crimmins EM.

Womens Health Issues. 2007 Nov-Dec;17(6):338-41. Epub 2007 Oct 22. Review. No abstract available.

PMID:
17936641
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The GATE frame: critical appraisal with pictures.

Jackson R, Ameratunga S, Broad J, Connor J, Lethaby A, Robb G, Wells S, Glasziou P, Heneghan C.

Evid Based Med. 2006 Apr;11(2):35-8. No abstract available.

PMID:
17213070
[PubMed - indexed for MEDLINE]
11.

Estrogen with and without progestin: benefits and risks of short-term use.

LaCroix AZ.

Am J Med. 2005 Dec 19;118 Suppl 12B:79-87.

PMID:
16414331
[PubMed - indexed for MEDLINE]
12.

Effect of estrogen therapy on gallbladder disease.

Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, Larson JC.

JAMA. 2005 Jan 19;293(3):330-9.

PMID:
15657326
[PubMed - indexed for MEDLINE]
13.

Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.

Shapiro S.

Climacteric. 2003 Dec;6(4):302-10; discussion 310-3.

PMID:
15006251
[PubMed - indexed for MEDLINE]
14.
15.

The SOGC statement on the WHI report on estrogen and progestin use in postmenopausal women.

Blake JM, Collins JA, Reid RL, Fedorkow DM, Lalonde AB, Christilaw J, Fortier M, Fortin C, Jolly EE, Lemay A, O'Grady T, Smith TE, Cooper J, Maxted JM, O'Grady K, Turek MA; SOGC (Society of Obstetricians and Gynaecologists of Canada).

J Obstet Gynaecol Can. 2002 Oct;24(10):783-90, 793-802. English, French.

PMID:
12399806
[PubMed - indexed for MEDLINE]
16.

Translating the latest scientific advances into clinical practice.

Reid RL.

J Obstet Gynaecol Can. 2002 Oct;24(10):771-4, 776-9. English, French. No abstract available.

PMID:
12399803
[PubMed - indexed for MEDLINE]
17.

Who says it's 'best practice'?

Mason DJ.

Am J Nurs. 2002 Oct;102(10):7. No abstract available.

PMID:
12394295
[PubMed - indexed for MEDLINE]
18.

Good science or good marketing?

Head K.

Altern Med Rev. 2002 Aug;7(4):274-5. No abstract available.

PMID:
12197780
[PubMed - indexed for MEDLINE]
19.

Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II).

Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N; HERS Research Group.

JAMA. 2002 Jul 3;288(1):49-57. Erratum in: JAMA 2002 Sep 4;288(9):1064.

PMID:
12090862
[PubMed - indexed for MEDLINE]
20.

Does estrogen/progestin therapy in post-menopausal women decrease their risk of fracture?

Groh KW, Stevermer JJ.

J Fam Pract. 2001 Nov;50(11):926. No abstract available.

PMID:
11711004
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk